# PHAR PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/PHAR
Company: Pharming Group

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with PHAR.

## PHAR PDUFA Milestones

- 2026-02-01 — CRL — FDA issued Complete Response Letter. The sponsor reported that FDA issued a Complete Response Letter for JOENJA (leniolisib) on February 1, 2026. This list-o...
  Company: Pharming Group
  Source: https://www.globenewswire.com/news-release/2026/02/01/3229924/0/en/Pharming-Group-receives-Complete-Response-Letter-from-U-S-FDA-for-sNDA-for-Joenja-leniolisib-in-children-aged-4-to-11-years-with-APDS.html
  Event detail: https://biopharmsignal.com/pdufa-calendar/PHAR/joenja-leniolisib-joenja-pediatric-snda.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/february (February 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/PHAR
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the PHAR PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with PHAR, including decision dates, application stage, and summary details when available.
### Where can I find more context for PHAR?

Use the BioPharmSignal company page for PHAR to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.